The Demise of Short-Acting Beta-Agonist Therapy The Demise of Short-Acting Beta-Agonist Therapy

According to Dr Aaron Holley, the 2019 Global Initiative for Asthma guidelines will change how pulmonologists have been practicing for many, many years.Medscape Critical Care
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine Viewpoint Source Type: news